U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.2242G>T (p.Glu748Ter) AND Malignant tumor of breast

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 10, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001844259.2

Allele description [Variation Report for NM_000465.4(BARD1):c.2242G>T (p.Glu748Ter)]

NM_000465.4(BARD1):c.2242G>T (p.Glu748Ter)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.2242G>T (p.Glu748Ter)
HGVS:
  • NC_000002.12:g.214728768C>A
  • NG_012047.3:g.85944G>T
  • NM_000465.4:c.2242G>TMANE SELECT
  • NM_001282543.2:c.2185G>T
  • NM_001282545.2:c.889G>T
  • NM_001282548.2:c.832G>T
  • NM_001282549.2:c.703G>T
  • NP_000456.2:p.Glu748Ter
  • NP_001269472.1:p.Glu729Ter
  • NP_001269474.1:p.Glu297Ter
  • NP_001269477.1:p.Glu278Ter
  • NP_001269478.1:p.Glu235Ter
  • LRG_297t1:c.2242G>T
  • LRG_297:g.85944G>T
  • LRG_297p1:p.Glu748Ter
  • NC_000002.11:g.215593492C>A
  • NG_012047.2:g.85937G>T
  • NM_000465.2:c.2242G>T
  • NM_000465.3:c.2242G>T
  • NR_104212.2:n.2207G>T
  • NR_104215.2:n.2150G>T
  • NR_104216.2:n.1406G>T
Protein change:
E235*
Links:
dbSNP: rs879253880
NCBI 1000 Genomes Browser:
rs879253880
Molecular consequence:
  • NR_104212.2:n.2207G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.2150G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104216.2:n.1406G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000465.4:c.2242G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001282543.2:c.2185G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001282545.2:c.889G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001282548.2:c.832G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001282549.2:c.703G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Malignant tumor of breast
Synonyms:
Malignant breast neoplasm; Cancer breast
Identifiers:
MONDO: MONDO:0007254; MedGen: C0006142

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002103498Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Feb 10, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002103498.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: BARD1 c.2242G>T (p.Glu748X) results in a premature termination codon, predicted to cause a truncation of the encoded protein, which is a commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic/likely pathogenic in ClinVar. The variant is not expected to cause nonsense mediated decay, but is expected to impact translation of the last 29 amino acids, including a portion of the BRCT domain (IPR001357). The variant was absent in 251284 control chromosomes (gnomAD). To our knowledge, no occurrence of c.2242G>T in individuals affected with Breast Cancer and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submitters have assessed the variant since 2014: both classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 8, 2024